Gilead Sciences, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
20,37
Forward P/E Ratio
14,36
PEG Ratio
0,88
13,02
Price-to-Sales (TTM)
5,82
7,55
18,29
Market Cap
172,28B
189,80B
Is it profitable?
Net Profit Margin (TTM)
28,90%
Gross Profit Margin
79,51%
Diluted EPS (TTM)
6,78
40,66%
29,44B
Is it growing?
4,70%
22,40%
Is it risky?
0,40
112,92
1,55
25,54B
Who owns it?
92,69%
0,13%
1,61%
1,24B
1,24B
Does it pay?
2,36%
46,61%
Mar 13, 2026
Mar 30, 2026
How much cash?
9,61B
10,02B
7,54B
7,74
- Price
- 141,54
- Percent Change
- +2,74 (1,97%)
- Previous Close
- 138,80
- Open
- 139,53
- Low
- 138,51
- High
- 141,44
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$141,54
From 52W Low
+51.59%
From 52W High
-10.01%
Today
+1.97%
1Y Change
+34.48%
6M
$116,74
3M
$121,10
1M
$146,63
Today
$141,54
From 52W Low
+51.59%
From 52W High
-10.01%
Today
+1.97%
1Y Change
+34.48%
6M
$116,74
3M
$121,10
1M
$146,63
Today
$141,54
Above Average
within its 1-year price range
$141,54
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-3.5%
3M
+16.9%
6M
+21.2%
1Y
+34.5%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Gilead Sciences, Inc.
- Founded
- Jun 22, 1987
- Founders
- Michael L. Riordan
- CEO
- Daniel P. O'Day
- Employees
- 17.000
- Fiscal Year End
- Dec 31, 2025
- Address
333 Lakeside Drive
Foster City
California
94404
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.gilead.com
Indicators
Operating Cash Flow
10,02B
Net Income
8,51B
Backed by Cash
1.18
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
10,02B
Net Income
8,51B
Backed by Cash
1.18
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
20,37
Forward P/E Ratio
14,36
PEG Ratio
0,88
13,02
Price-to-Sales (TTM)
5,82
7,55
18,29
Market Cap
172,28B
189,80B
Is it profitable?
Net Profit Margin (TTM)
28,90%
Gross Profit Margin
79,51%
Diluted EPS (TTM)
6,78
40,66%
29,44B
Is it growing?
4,70%
22,40%
Is it risky?
0,40
112,92
1,55
25,54B
Who owns it?
92,69%
0,13%
1,61%
1,24B
1,24B
Does it pay?
2,36%
46,61%
Mar 13, 2026
Mar 30, 2026
How much cash?
9,61B
10,02B
7,54B
7,74
- Price
- 141,54
- Percent Change
- +2,74 (1,97%)
- Previous Close
- 138,80
- Open
- 139,53
- Low
- 138,51
- High
- 141,44
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$141,54
From 52W Low
+51.59%
From 52W High
-10.01%
Today
+1.97%
1Y Change
+34.48%
6M
$116,74
3M
$121,10
1M
$146,63
Today
$141,54
From 52W Low
+51.59%
From 52W High
-10.01%
Today
+1.97%
1Y Change
+34.48%
6M
$116,74
3M
$121,10
1M
$146,63
Today
$141,54
Above Average
within its 1-year price range
$141,54
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-3.5%
3M
+16.9%
6M
+21.2%
1Y
+34.5%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Gilead Sciences, Inc.
- Founded
- Jun 22, 1987
- Founders
- Michael L. Riordan
- CEO
- Daniel P. O'Day
- Employees
- 17.000
- Fiscal Year End
- Dec 31, 2025
- Address
333 Lakeside Drive
Foster City
California
94404
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.gilead.com